R Buelow Selected Research

allotrap

5/2003	RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
1/2003	RDP58, a Novel Immunomodulatory Peptide with Anti-Inflammatory Effects. A Pharmacological Study in Trinitrobenzene Sulphonic Acid Colitis and Crohn Disease.
11/2002	RDP58, a locally active TNF inhibitor, is effective in the dextran sulphate mouse model of chronic colitis.
11/2002	Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis.
2/2001	Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Buelow Research Topics

Disease

5	Inflammation (Inflammations) 05/2003 - 02/2001
4	Colitis 05/2003 - 11/2002
2	Weight Loss (Weight Reduction) 05/2003 - 01/2003
2	Crohn Disease (Crohn's Disease) 05/2003 - 01/2003
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2002
1	Necrosis 11/2002
1	Arteriosclerosis 05/2002
1	Reperfusion Injury 07/2001
1	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2000

Drug/Important Bio-Agent (IBA)

5	allotrapIBA 05/2003 - 02/2001
4	Heme Oxygenase-1IBA 05/2003 - 02/2000
2	AcidsIBA 05/2003 - 01/2003
2	Dextrans (Dextran)FDA Link 11/2002 - 11/2002
2	SodiumIBA 11/2002 - 11/2002
1	Peptides (Polypeptides)IBA 11/2002
1	Tumor Necrosis Factor InhibitorsIBA 11/2002
1	cobaltiprotoporphyrinIBA 02/2000

Therapy/Procedure

4	Therapeutics 05/2003 - 11/2002
2	Rectal Administration 05/2003 - 01/2003
1	Oral Administration 11/2002
1	Liver Transplantation 07/2001